Discovery of potent, orally active, irreversible Her-2 receptor tyrosine kinase inhibitor reported July 16, 2003
Caspase-dependent cell-killing and TRAIL-sensitizing effects reported for estrogen derivative July 16, 2003
South Korean scientists report synthesis and biological evaluation of promising antitumor retinoid July 16, 2003